• Explore /
  • Poster
  • / Real-world effectiveness and safety of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: A retrospective observational study using an administrative database.

Real-world effectiveness and safety of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: A retrospective observational study using an administrative database.

Abstract Poster

Authors

null

Eiji Shinozaki

The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Tokyo, Japan;

Eiji Shinozaki , Yoshinori Kagawa , Ryota Okude , Takuma Tone , Yuji Kunitomi , Masayuki Nakashima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 44)

DOI

10.1200/JCO.2023.41.4_suppl.44

Abstract #

44

Poster Bd #

B19

Abstract Disclosures

Similar Posters

First Author: Julien Taieb

First Author: Yoshinori Kagawa

First Author: Carlo Signorelli

First Author: Marwan Fakih